Skip to main content
NIH funding notice PAR-11-301

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)

Closed on September 4, 2013.

Posted
August 11, 2011
Close date
September 4, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $336,150 in first-year total cost, median $336,150.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 ETTN-B (50)]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
Competing awards under PAR-11-301 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Postnatal combination therapy for cerebral palsy1R01HD076901-01A1RANGARAMANUJAM, KANNANJOHNS HOPKINS UNIVERSITY, MD$336,150ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.